Patent reform markup
Executive Summary
A markup of sweeping legislation to update the U.S. patent system for the first time in 50 years remains on the Senate Judiciary Committee's agenda for June 21 after being held over last week to allow further deliberation. A letter from several Republican committee members to Committee Chair Patrick Leahy, D-Vt., and Ranking Member Arlen Specter, R-Penn., says additional discussion among members, staff, the Patent and Trademark Office, the Department of Justice, and stakeholders is needed. The bill has moved rapidly through both houses of Congress, with contentious provisions including mandatory apportionment of damages, post-grant opposition, the granting of broad rule-making authority to PTO, and possible amendment of the Inequitable Conduct Doctrine (1"The Pink Sheet," June 11, 2007, p. 8)...
You may also be interested in...
PTO Wants Inequitable Conduct Doctrine Revised in Patent Reform Bill
With identical patent reform legislation moving rapidly through both houses of Congress, the U.S. Patent and Trademark Office is asking that the inequitable conduct doctrine be revised to encourage applicants to provide more and better information to examiners about their inventions
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.